PUT - SPRINTER OPEN END - PFIZER INC Stock

Certificat

DE000VX4TP90

Delayed Deutsche Boerse AG 04:17:53 2024-05-27 EDT
3 EUR 0.00% Intraday chart for PUT - SPRINTER OPEN END - PFIZER INC
1 month-9.37%
3 months-3.23%
Date Price Change
24-05-27 3 0.00%
24-05-24 3 0.00%
24-05-23 3 +1.69%
24-05-22 2.95 -2.32%
24-05-21 3.02 +0.67%

Delayed Quote Deutsche Boerse AG

Last update May 27, 2024 at 04:17 am

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VX4TP9
ISINDE000VX4TP90
Date issued 2021-12-16
Strike 61.25 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.56
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 3.41
Lowest since issue 0.37
Spread 0.02
Spread %0.66%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.88 USD
Average target price
31.94 USD
Spread / Average Target
+10.59%
Consensus